213 related articles for article (PubMed ID: 34341167)
1.
Hutcherson SM; Bedsaul JR; Pomerantz JL
J Immunol; 2021 Aug; 207(4):1150-1164. PubMed ID: 34341167
[TBL] [Abstract][Full Text] [Related]
2. Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience.
Urdinez L; Erra L; Palma AM; Mercogliano MF; Fernandez JB; Prieto E; Goris V; Bernasconi A; Sanz M; Villa M; Bouso C; Caputi L; Quesada B; Solis D; Aguirre Bruzzo A; Katsicas MM; Galluzzo L; Weyersberg C; Bocian M; Bujan MM; Oleastro M; Almejun MB; Danielian S
Front Immunol; 2022; 13():1020927. PubMed ID: 36405754
[TBL] [Abstract][Full Text] [Related]
3. A Unique Heterozygous
Desjardins M; Arjunaraja S; Stinson JR; Dorjbal B; Sundaresan J; Niemela J; Raffeld M; Matthews HF; Wang A; Angelus P; Su HC; Mazer BD; Snow AL
Front Immunol; 2018; 9():2944. PubMed ID: 30619304
[TBL] [Abstract][Full Text] [Related]
4. Identification and Characterization of a Germline Mutation in CARD11 From a Chinese Case of B Cell Expansion With NF-κB and T Cell Anergy.
Zhao P; Meng Q; Huang Y; Zhang L; Luo S; Zhang X; Tan L; Zhou A; Xiong H; He X
Front Immunol; 2021; 12():676386. PubMed ID: 34557185
[TBL] [Abstract][Full Text] [Related]
5. Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11).
Dadi H; Jones TA; Merico D; Sharfe N; Ovadia A; Schejter Y; Reid B; Sun M; Vong L; Atkinson A; Lavi S; Pomerantz JL; Roifman CM
J Allergy Clin Immunol; 2018 May; 141(5):1818-1830.e2. PubMed ID: 28826773
[TBL] [Abstract][Full Text] [Related]
6. Management of Atopy with Dupilumab and Omalizumab in CADINS Disease.
Diaz-Cabrera NM; Bauman BM; Iro MA; Dabbah-Krancher G; Molho-Pessach V; Zlotogorski A; Shamriz O; Dinur-Schejter Y; Sharon TD; Stepensky P; Tal Y; Eisenstein EM; Pietzsch L; Schuetz C; Abreu D; Coughlin CC; Cooper MA; Milner JD; Williams A; Armoni-Weiss G; Snow AL; Leiding JW
J Clin Immunol; 2024 Jan; 44(2):48. PubMed ID: 38231347
[TBL] [Abstract][Full Text] [Related]
7. Hyper-IgE and Carcinoma in CADINS Disease.
Pietzsch L; Körholz J; Boschann F; Sergon M; Dorjbal B; Yee D; Gilly V; Kämmerer E; Paul D; Kastl C; Laass MW; Berner R; Jacobsen EM; Roesler J; Aust D; Lee-Kirsch MA; Snow AL; Schuetz C
Front Immunol; 2022; 13():878989. PubMed ID: 35651609
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic CARD11 mutations affect B cell development and differentiation through a noncanonical pathway.
Wei Z; Zhang Y; Chen J; Hu Y; Jia P; Wang X; Zhao Q; Deng Y; Li N; Zang Y; Qin J; Wang X; Lu W
Sci Immunol; 2019 Nov; 4(41):. PubMed ID: 31784498
[TBL] [Abstract][Full Text] [Related]
9. Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease.
Dorjbal B; Stinson JR; Ma CA; Weinreich MA; Miraghazadeh B; Hartberger JM; Frey-Jakobs S; Weidinger S; Moebus L; Franke A; Schäffer AA; Bulashevska A; Fuchs S; Ehl S; Limaye S; Arkwright PD; Briggs TA; Langley C; Bethune C; Whyte AF; Alachkar H; Nejentsev S; DiMaggio T; Nelson CG; Stone KD; Nason M; Brittain EH; Oler AJ; Veltri DP; Leahy TR; Conlon N; Poli MC; Borzutzky A; Cohen JI; Davis J; Lambert MP; Romberg N; Sullivan KE; Paris K; Freeman AF; Lucas L; Chandrakasan S; Savic S; Hambleton S; Patel SY; Jordan MB; Theos A; Lebensburger J; Atkinson TP; Torgerson TR; Chinn IK; Milner JD; Grimbacher B; Cook MC; Snow AL
J Allergy Clin Immunol; 2019 Apr; 143(4):1482-1495. PubMed ID: 30170123
[TBL] [Abstract][Full Text] [Related]
10. A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease.
Shields AM; Bauman BM; Hargreaves CE; Pollard AJ; Snow AL; Patel SY
J Clin Immunol; 2020 Feb; 40(2):406-411. PubMed ID: 31897776
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic impact of oligomer poisoning by dominant-negative CARD11 variants.
Bedsaul JR; Shah N; Hutcherson SM; Pomerantz JL
iScience; 2022 Feb; 25(2):103810. PubMed ID: 35198875
[TBL] [Abstract][Full Text] [Related]
12. Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3-positive regulatory versus T(H)2 effector cells to cause allergy.
Altin JA; Tian L; Liston A; Bertram EM; Goodnow CC; Cook MC
J Allergy Clin Immunol; 2011 May; 127(5):1277-85.e5. PubMed ID: 21320717
[TBL] [Abstract][Full Text] [Related]
13. Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease.
Arjunaraja S; Angelus P; Su HC; Snow AL
Front Immunol; 2018; 9():198. PubMed ID: 29472930
[No Abstract] [Full Text] [Related]
14. A novel CARD11 germline mutation in a Chinese patient of B cell expansion with NF-κB and T cell anergy (BENTA) and literature review.
Zhao P; Hu Y; Sun D; Meng Q; Zhang L; Zhang X; Tan L; Zhang Y; Ding Y; He X
Front Immunol; 2022; 13():943027. PubMed ID: 36203613
[TBL] [Abstract][Full Text] [Related]
15. Germline CARD11 Mutation in a Patient with Severe Congenital B Cell Lymphocytosis.
Brohl AS; Stinson JR; Su HC; Badgett T; Jennings CD; Sukumar G; Sindiri S; Wang W; Kardava L; Moir S; Dalgard CL; Moscow JA; Khan J; Snow AL
J Clin Immunol; 2015 Jan; 35(1):32-46. PubMed ID: 25352053
[TBL] [Abstract][Full Text] [Related]
16. CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis.
Baronio M; Gazzurelli L; Rezzola S; Rossi S; Tessarin G; Marinoni M; Salpietro A; Fiore M; Moratto D; Chiarini M; Badolato R; Parolini S; Tabellini G; Lougaris V
Immunobiology; 2023 May; 228(3):152381. PubMed ID: 37086690
[TBL] [Abstract][Full Text] [Related]
17. Elevated IgE from attenuated CARD11 signaling: lessons from atopic mice and humans.
Pomerantz JL; Milner JD; Snow AL
Curr Opin Immunol; 2022 Dec; 79():102255. PubMed ID: 36334349
[TBL] [Abstract][Full Text] [Related]
18. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
Knies N; Alankus B; Weilemann A; Tzankov A; Brunner K; Ruff T; Kremer M; Keller UB; Lenz G; Ruland J
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7230-8. PubMed ID: 26668357
[TBL] [Abstract][Full Text] [Related]
19. Germline hypomorphic CARD11 mutations in severe atopic disease.
Ma CA; Stinson JR; Zhang Y; Abbott JK; Weinreich MA; Hauk PJ; Reynolds PR; Lyons JJ; Nelson CG; Ruffo E; Dorjbal B; Glauzy S; Yamakawa N; Arjunaraja S; Voss K; Stoddard J; Niemela J; Zhang Y; Rosenzweig SD; McElwee JJ; DiMaggio T; Matthews HF; Jones N; Stone KD; Palma A; Oleastro M; Prieto E; Bernasconi AR; Dubra G; Danielian S; Zaiat J; Marti MA; Kim B; Cooper MA; Romberg N; Meffre E; Gelfand EW; Snow AL; Milner JD
Nat Genet; 2017 Aug; 49(8):1192-1201. PubMed ID: 28628108
[TBL] [Abstract][Full Text] [Related]
20.
Masle-Farquhar E; Jeelall Y; White J; Bier J; Deenick EK; Brink R; Horikawa K; Goodnow CC
Front Immunol; 2023; 14():1095257. PubMed ID: 36960072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
